Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface
Molecular Pharmaceutics · 03.04.2023 · 20 (4) · 2217-2234
DOI: 10.1021/acs.molpharmaceut.3c00020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 16.03.2023. Verfasst von Alexandru Deac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States. Hauptthemen laut MEDLINE: Vinyl Compounds, Polymers. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: AbbVie.
Abstract (Originalsprache)
Despite the recent success of amorphous solid dispersions (ASDs) at enabling the delivery of poorly soluble small molecule drugs, ASD-based dosage forms are limited by low drug loading. This is partially due to a sharp decline in drug release from the ASD at drug loadings surpassing the 'limit of congruency' (LoC). In some cases, the LoC is as low as 5% drug loading, significantly increasing the risk of pill burden. Despite efforts to understand the mechanism responsible for the LoC, a clear picture of the molecular processes occurring at the ASD/solution interface remains elusive. In this study, the ASD/solution interface was studied for two model compounds formulated as ASDs with copovidone. The evolution of a gel layer and its phase behavior was captured in situ with fluorescence confocal microscopy, where fluorescent probes were added to label the hydrophobic and hydrophilic phases. Phase separation was detected in the gel layer for most of the ASDs. The morphology of the hydrophobic phase was found to correlate with the release behavior, where a discrete phase resulted in good release and a continuous phase formed a barrier leading to poor release. The continuous phase formed at a lower drug loading for the system with stronger drug-polymer interactions. This was due to incorporation of the polymer into the hydrophobic phase. The study highlights the complex molecular and phase behavior at the ASD/solution interface of copovidone-based ASDs and provides a thermodynamic argument for qualitatively predicting the release behavior based on drug-polymer interactions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, West Lafayette, Indiana 47907, United States.
- Development Sciences, Research and Development, AbbVie Inc., North Chicago, Illinois 60064, United States.
ORCID-Profile: Alexandru Deac, Geoff G Z Zhang, Lynne S Taylor
Förderung
- AbbVie
Zitieren
APA
Deac, A., Qi, Q., Indulkar, A. S., Gao, Y., Zhang, G. G. Z., & Taylor, L. S. (2023). Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface. Molecular Pharmaceutics, 20(4), 2217-2234. https://doi.org/10.1021/acs.molpharmaceut.3c00020
Vancouver
Deac A, Qi Q, Indulkar AS, Gao Y, Zhang GGZ, Taylor LS. Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface. Molecular Pharmaceutics. 2023;20(4):2217-2234. doi:10.1021/acs.molpharmaceut.3c00020
BibTeX
@article{Deac2023,
author = {Deac, Alexandru and Qi, Qingqing and Indulkar, Anura S and Gao, Yi and Zhang, Geoff G Z and Taylor, Lynne S},
title = {Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface},
journal = {Molecular Pharmaceutics},
year = {2023},
volume = {20},
number = {4},
pages = {2217--2234},
doi = {10.1021/acs.molpharmaceut.3c00020}
}
EUVIMED